학술논문

A circulating cell-free DNA methylation signature for the detection of hepatocellular carcinoma.
Document Type
Article
Source
Molecular Cancer. 10/6/2023, Vol. 22 Issue 1, p1-6. 6p.
Subject
*CIRCULATING tumor DNA
*DNA methylation
*CELL-free DNA
*HEPATOCELLULAR carcinoma
*POLYMERASE chain reaction
*LACTATE dehydrogenase
Language
ISSN
1476-4598
Abstract
To address the shortcomings of current hepatocellular carcinoma (HCC) surveillance tests, we set out to find HCC-specific methylation markers and develop a highly sensitive polymerase chain reaction (PCR)-based method to detect them in circulating cell-free DNA (cfDNA). The analysis of large methylome data revealed that Ring Finger Protein 135 (RNF135) and Lactate Dehydrogenase B (LDHB) are universally applicable HCC methylation markers with no discernible methylation level detected in any other tissue types. These markers were used to develop Methylation Sensitive High-Resolution Analysis (MS-HRM), and their diagnostic accuracy was tested using cfDNA from healthy, at-risk, and HCC patients. The combined MS-HRM RNF135 and LDHB analysis detected 57% of HCC, outperforming the alpha-fetoprotein (AFP) test's sensitivity of 45% at comparable specificity. Furthermore, when used with the AFP test, the methylation assay can detect 70% of HCC. Our findings suggest that the cfDNA methylation assay could be used for HCC liquid biopsy. [ABSTRACT FROM AUTHOR]